Amgen reported for 9 months of 2023

Amgen's GAAP net income for 9 months of 2023 was $5.95 billion, up 20.4% from $4.94 billion in the prior year. Revenue increased by 2.6% to $19.994 bln vs. $19.484 bln a year earlier.